Genetic counseling practice in next generation sequencing research: Implications for the ethical oversight of the informed consent process

Journal of Genetic Counseling

Volumn 23, Issue 4, 2014, Pages 661-670

  Egalite, Nathalie ^a   Groisman, Iris Jaitovich ^a   Godard, Beatrice ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Consent forms; Ethical issues; Genetic counseling; Genetic research; Incidental findings; Informed consent; Next generation sequencing; Return of results

Indexed keywords

ETHICS; GENETIC COUNSELING; HUMAN; INFORMED CONSENT; PROCEDURES; SEQUENCE ANALYSIS;

ETHICS; GENETIC COUNSELING; HUMANS; INFORMED CONSENT; SEQUENCE ANALYSIS;

EID: 84904254578     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9703-x     Document Type: Article

References (45)

1. Allen, C.; Foulkes, W. D. (2011). Qualitative thematic analysis of consent forms used in cancer genome sequencing. BMC Medical Ethics, 12, 14.
2. Austin, J. C.; Honer, W. G. (2007). The genomic era and serious mental illness: a potential application for psychiatric genetic counseling. Psychiatric Services, 58(2), 254-261.
3. Baret, L.; Godard, B. (2011). Opinions and intentions of parents of an autistic child toward genetic research results: two typical profiles. European Journal of Human Genetics, 19(11), 1127-1132.
4. Biesecker, B. B. (2001). Goals of genetic counseling. Clinical Genetics, 60, 323-330.
5. Biesecker, B. B.; Peay, H. L. (2003). Ethical issues in psychiatric genetics research: points to consider. Psychopharmacology, 171(1), 27-35.
6. Braggio, E.; Egan, J. B.; Fonseca, R.; Stewart, A. K. (2013). Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer Journal, 3, e127.
7. Bras, J.; Guerreiro, R.; Hardy, J. (2012). Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nature Review Neuroscience, 13(7), 453-464.
8. Bredenoord, A. L.; Kroes, H. Y.; Cuppen, E.; Parker, M.; van Delden, J. J. (2011). Disclosure of individual genetic data to research participants: the debate reconsidered. Trends in Genetics, 27(2), 41-47.
9. Brenner, S.; Johnson, M.; Bridgham, J.; Golda, G.; Lloyd, D. H.; Johnson, D.; et al. (2000). Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nature Biotechnology, 18(6), 630-634. doi: 10.1038/76469.
10. Canadian Association of Genetic Counsellors. (2008). Genetic Counselling: A brochure for Canadians seeking assisted human reproduction procedures. Retrieved from https://cagc-accg.ca/images/docs/genetic-c-eng%20sm.pdf. Accessed 5 Sept 2013.
11. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, & Social Sciences and Humanities Research Council of Canada. (2010). Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2). Retrieved from http://www.pre.ethics.gc.ca/ pdf/eng/tcps2/TCPS-2-FINAL-Web.pdf. Accessed 22 Oct 2012.
12. Council for International Organization of Medical Sciences. (2002). International ethical guidelines for biomedical research involving human subjects. Geneva: CIOMS.
13. Cowan, J.; Morales, A.; Dagua, J.; Hershberger, R. E. (2008). Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations. Congestive Heart Failure, 14(2), 97-105.
14. de Ligt, J.; Willemsen, M. H.; van Bon, B. W.; Kleefstra, T.; Yntema, H. G.; Kroes, T.; et al. (2012). Diagnostic exome sequencing in persons with severe intellectual disability. New England Journal of Medicine, 367(20), 1921-1929.
15. Dove, E. S.; Avard, D.; Black, L.; Knoppers, B. M. (2013). Emerging issues in paediatric health research consent forms in Canada: working towards best practices. BMC Medical Ethics, 14, 5.
16. Finn, C. T.; Smoller, J. W. (2006). Genetic counseling in psychiatry. Harvard Review of Psychiatry, 14(2), 109-121.
17. Gershon, E. S. (2013). Risk counselling for family members in bipolar disorder and schizophrenia. International Journal of Neuropsychopharmacology, 16(3), 713-714.
18. Gilissen, C.; Hoischen, A.; Brunner, H. G.; Veltman, J. A. (2012). Disease gene identification strategies for exome sequencing. European Journal of Human Genetics, 20(5), 490-497.
19. Green, R. C.; Berg, J. S.; Grody, W. W.; Kalia, S. S.; Korf, B. R.; Martin, C. L.; et al. (2013). ACMG Recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565-574.
20. Groisman, I. J.; Mathieu, G.; Godard, B. (2012). Use of next generation sequencing technologies in research and beyond: are participants with mental health disorders fully protected? BMC Medical Ethics, 13(1), 36.
21. Hawkins, A. K.; Ho, A. (2012). Genetic counseling and the ethical issues around direct to consumer genetic testing. Journal of Genetic Counseling, 21(3), 367-373.
22. Hoge, S. K.; Appelbaum, P. S. (2012). Ethics and neuropsychiatric genetics: a review of major issues. International Journal of Neuropsychopharmacology, 25, 1-11.
23. Hoop, J. G. (2008). Ethical considerations in psychiatric genetics. Harvard Review of Psychiatry, 16(6), 322-338.
24. Johnson, J. O.; Mandrioli, J.; Benatar, M.; Abramzon, Y.; Van Deerlin, V. M.; Trojanowski, J. Q.; et al. (2010). Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron, 68(5), 857-864.
25. Kaye, J.; Boddington, P.; de Vries, J.; Hawkins, N.; Melham, K. (2010). Ethical implications of the use of whole genome methods in medical research. European Journal of Human Genetics, 18(4), 398-403.
26. Kiezun, A.; Garimella, K.; Do, R.; Stitziel, N. O.; Neale, B. M.; McLaren, P. J.; et al. (2012). Exome sequencing and the genetic basis of complex traits. Nature Genetics, 44(6), 623-630.
27. Knoppers, B. M.; Joly, Y.; Simard, J.; Durocher, F. (2006). The emergence of an ethical duty to disclose genetic research results: international perspectives. European Journal of Human Genetics, 14(11), 1170-1178.
28. Krier, J. B.; Green, R. C. (2013). Management of incidental findings in clinical genomic sequencing. Current Protocols in Human Genetics, 77, 9.23.1-9.23.13.
29. Lyon, G.; Jiang, T.; Van Wijk, R.; Wang, W.; Bodily, P.; Xing, J.; et al. (2011). Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications. Discovery Medicine, 12(62), 41-55.
30. Markel, D. S.; Yashar, B. M. (2004). The interface between the practice of medical genetics and human genetic research: what every genetic counselor needs to know. Journal of Genetic Counseling, 13(5), 351-368.
31. Mathieu, G.; Groisman, I. J.; Godard, B. (2013). Next generation sequencing in psychiatric research: what study participants need to know about research findings. The International Journal of Neuropsychopharmacology, 16(9), 2119-2127.
32. McGuire, A. L.; Caulfield, T.; Cho, M. K. (2008). Research ethics and the challenge of whole-genome sequencing. Nature Reviews Genetics, 9, 152-156.
33. McMahon, W. M.; Baty, B. J.; Botkin, J. (2006). Genetic counseling and ethical issues for autism. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(1), 52-57.
34. Meltzer, L. A. (2006). Undesirable implications of disclosing individual genetic results to research participants. The American Journal of Bioethics, 6(6), 28-30.
35. Metzker, M. L. (2010). Sequencing technologies - the next generation. Nature Reviews Genetics, 11(1), 31-46.
36. National Society of Genetic Counselors. (2006). The code of ethics of the National Society of Genetic Counselors. Journal of Genetic Counseling, 15(5), 309-311.
37. Ng, S. B.; Buckingham, K. J.; Lee, C.; Bigham, A. W.; Tabor, H. K.; Dent, K. M.; et al. (2010). Exome sequencing identifies the cause of a mendelian disorder. Nature Genetics, 42(1), 30-35.
38. Panoutsopoulou, K.; Tachmazidou, I.; Zeggini, E. (2013). In search of low-frequency and rare variants affecting complex traits. Human Molecular Genetics, 22(R1), R16-R21.
39. Parker, L. S. (2002). Ethical issues in bipolar disorders pedigree research: privacy concerns, informed consent, and grounds for waiver. Bipolar Disorders, 4(1), 1-16.
40. Rotimi, C.; Marshall, P. (2010). Tailoring the process of informed consent in genetic and genomic research. Genome Medicine, 2(3), 20.
41. Sijmons, R. H.; Van Langen, I. M.; Sijmons, J. G. (2011). A clinical perspective on ethical issues in genetic testing. Accountability in Research, 18(3), 148-162.
42. Simon, C. M.; Williams, J. K.; Shinkunas, L.; Brandt, D.; Daack-Hirsch, S.; Driessnack, M. (2011). Informed consent and genomic incidental findings: IRB chair perspectives. Journal of Empirical Research on Human Research Ethics, 6(4), 53-67.
43. Tabor, H. K.; Berkman, B. E.; Hull, S. C.; Bamshad, M. J. (2011). Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. American Journal of Medical Genetics Part A, 155A(12), 2916-2924.
44. Tabor, H. K.; Stock, J.; Brazg, T.; McMillin, M. J.; Dent, K. M.; Yu, J. H.; et al. (2012). Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. American Journal of Medical Genetics Part A, 158A(6), 1310-1319.
45. Vaismoradi, M.; Turunen, H.; Bondas, T. (2013). Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nursing & Health Sciences, 15(3), 398-405.